A Year Of Change: Sandoz Completes A Transformational 2023
Spinoff From Novartis Caps A Year That Also Saw Plenty Of Deals And Launches
Executive Summary
An eventful 2023 for Sandoz saw multiple major deals and key launches, with the year culminating in the firm’s long-awaited spinoff from parent company Novartis in October.